Bio-Rad Laboratories (BIO) Competitors $298.30 -2.33 (-0.78%) As of 10/10/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Do insiders & institutionals believe in MTD or BIO? 95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by company insiders. Comparatively, 17.1% of Bio-Rad Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer MTD or BIO? In the previous week, Mettler-Toledo International had 12 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 14 mentions for Mettler-Toledo International and 2 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.43 beat Mettler-Toledo International's score of 0.89 indicating that Bio-Rad Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Rad Laboratories 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate MTD or BIO? Mettler-Toledo International presently has a consensus target price of $1,336.50, indicating a potential upside of 4.87%. Bio-Rad Laboratories has a consensus target price of $333.50, indicating a potential upside of 11.80%. Given Bio-Rad Laboratories' higher probable upside, analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42Bio-Rad Laboratories 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more volatility & risk, MTD or BIO? Mettler-Toledo International has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Which has preferable valuation and earnings, MTD or BIO? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$3.87B6.78$863.14M$39.4932.27Bio-Rad Laboratories$2.57B3.15-$1.84B$11.7325.43 Is MTD or BIO more profitable? Mettler-Toledo International has a net margin of 21.46% compared to Bio-Rad Laboratories' net margin of 12.50%. Bio-Rad Laboratories' return on equity of 4.01% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International21.46% -476.07% 26.05% Bio-Rad Laboratories 12.50%4.01%2.82% SummaryMettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$8.14B$10.76B$6.10B$21.91BDividend YieldN/A1.88%5.67%3.61%P/E Ratio25.4320.2785.2728.85Price / Sales3.1530.81612.7883.44Price / Cash28.9325.5838.5024.17Price / Book1.273.3712.724.51Net Income-$1.84B$208.83M$3.30B$1.01B7 Day Performance-2.35%-2.89%0.94%-3.45%1 Month Performance4.33%-1.01%6.34%-1.85%1 Year Performance-11.46%-6.90%80.41%10.34% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.3852 of 5 stars$298.30-0.8%$333.50+11.8%-10.5%$8.14B$2.57B25.437,700Positive NewsMTDMettler-Toledo International3.9343 of 5 stars$1,191.70-1.1%$1,325.56+11.2%-11.5%$24.81B$3.87B30.1817,300Analyst ForecastWATWaters4.3836 of 5 stars$289.19-0.9%$378.73+31.0%-5.9%$17.36B$2.96B26.087,600Trending NewsAnalyst ForecastILMNIllumina4.7277 of 5 stars$91.87+0.2%$123.06+33.9%-34.7%$14.09B$4.37B11.639,030Analyst ForecastTECHBio-Techne4.7583 of 5 stars$52.23+0.7%$70.42+34.8%-19.6%$8.07B$1.22B113.553,100Analyst ForecastCRLCharles River Laboratories International4.2071 of 5 stars$146.88-1.1%$177.07+20.6%-12.7%$7.31B$4.05B-110.4320,100Analyst DowngradeBRKRBruker4.9482 of 5 stars$30.88-0.5%$51.30+66.1%-44.6%$4.71B$3.37B59.3911,396Analyst ForecastPACBPacific Biosciences of California1.9157 of 5 stars$1.25+3.3%$1.90+52.0%-8.4%$363.45M$154.01M-0.55730Analyst ForecastHBIOHarvard Bioscience4.342 of 5 stars$0.44-0.9%$2.00+354.8%-81.9%$19.77M$94.14M-0.34490Analyst ForecastTMOThermo Fisher Scientific4.9036 of 5 stars$461.95-0.5%$588.35+27.4%-11.6%$175.30B$42.88B26.72125,000Positive NewsAnalyst ForecastAAgilent Technologies4.0903 of 5 stars$123.70+0.3%$140.08+13.2%-4.3%$34.98B$6.51B29.0417,900Analyst Forecast Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
